Interferon for pancreatic cancer

Interferon is known to have anti-proliferative effects against pancreatic cancer cells and mesothelioma. Unfortunately, clinical evidence for effectiveness is lacking. Most available studies had been in adjuvant settings where the drug’s anti-angiogenic(blood vessel formation) properties may be most prominent. A few metastatic studies do not demonstrate a marked benefit of adding interferon to chemotherapy.


NeoPlas Innovation’s Stephen Cantrell, M.D., has opened a clinic where he uses lovastatin with interferon for a variety of cancer diagnosis. We await peer-reviewed publications on the results of this approach.

Read the Professional version here.

Participate in our Forums

To ask questions or participate in a discussion, please visit our Forums. You must LOGIN to participate.

Help Us Help Others

You can become a Site Sponsor. Or you may wish to support our work with a Donation.

Focused Articles For You

Lay Portal